These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 1868442

  • 1. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.
    Trown PW, Reardan DT, Carroll SF, Stoudemire JB, Kawahata RT.
    Cancer Res; 1991 Aug 15; 51(16):4219-25. PubMed ID: 1868442
    [Abstract] [Full Text] [Related]

  • 2. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T, Raso V.
    Cancer Res; 1991 Aug 15; 51(16):4316-22. PubMed ID: 1868454
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS, Pimm MV, Scannon PJ, Pawluczyk I, Baldwin RW.
    Cancer Res; 1987 Oct 01; 47(19):5042-6. PubMed ID: 3497715
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ, Cumber AJ, Henry RV, May J, Newell DR, Parnell GD, Worrell NR, Forrester JA.
    Cancer Res; 1990 Dec 01; 50(23):7519-26. PubMed ID: 2253201
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
    Blakey DC, Skilleter DN, Price RJ, Watson GJ, Hart LI, Newell DR, Thorpe PE.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7072-8. PubMed ID: 3263899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents.
    Byers VS, Pimm MV, Pawluczyk IZ, Lee HM, Scannon PJ, Baldwin RW.
    Cancer Res; 1987 Oct 15; 47(20):5277-83. PubMed ID: 3498532
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD.
    J Natl Cancer Inst; 1987 Nov 15; 79(5):1163-72. PubMed ID: 3500356
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A, Ettenson D, Bjorn MJ, Lei M, Baumal R.
    Cancer Res; 1990 Jan 15; 50(2):288-92. PubMed ID: 2295069
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H, Kamrath H, Apell G, Houston LL, Mendelsohn J.
    Cancer Res; 1989 Jul 01; 49(13):3482-8. PubMed ID: 2786451
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
    Calvete JA, Newell DR, Wright AF, Rose MS.
    Cancer Res; 1994 Sep 01; 54(17):4684-90. PubMed ID: 8062265
    [Abstract] [Full Text] [Related]

  • 15. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D, Sheldon K, Marks A, Houston LL, Baumal R.
    Anticancer Res; 1988 Sep 01; 8(4):833-8. PubMed ID: 3263079
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localization.
    Fulton RJ, Tucker TF, Vitetta ES, Uhr JW.
    Cancer Res; 1988 May 01; 48(9):2618-25. PubMed ID: 3258546
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA, Halloran PM, Ferris CA, Levine BA, Bourret LA, Goldmacher VS, Blättler WA.
    Cancer Res; 1993 Mar 15; 53(6):1360-7. PubMed ID: 7680284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.